Clinical Trials Information System (CTIS) bitesize talk: Training materials, CTIS pre-requisites, and updates on transparency rules, Online, European Medicines Agency, Amsterdam, the Netherlands, 29 November 2023

European Medicines Agency’s privacy statement for the operation of the Security Access Control System

European Medicines Agency’s privacy statement for the operation of video-surveillance (CCTV) system

Record of data processing activity relating to Security Access Control System (public)

Record of data processing activity relating to the filemaker security database for staff vehicles/bicycles and lost/found property (public)

List of substances and products subject to worksharing for signal management

Funding

Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 26, Status: Authorised

Brexit-related guidance for companies

Questions and answers to stakeholders on the implications of Regulation (EU) 2023/1182 for centrally authorised medicinal products for human use